EGFR is amplified and highly overexpressed in HNSCC and lung squamous cell carcinoma, frequently mutated and activated in lung adenocarcinoma (LUAC), and mutated, rearranged, and amplified in glioblastoma [41,72,73,74]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.